FDA Drug Shortages
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Start Over | Back to Previous Screen
Bupivacaine Hydrochloride Injection, USP
Status: Currently in Shortage
»Date first posted:
No date available
»Therapeutic Categories: Anesthesia
AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Revised 03/05/2019)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 0.25% 10 mL Single Dose Vials (NDC 55150-167-10) | Currently backordered | Additional quantities expected by mid-April | Demand increase for the drug |
| 0.25% 30 mL Single Dose Vials (NDC 55150-168-30) | Currently backordered | Additional quantities expected by early April | Demand increase for the drug |
| 0.5% 10 mL Single Dose Vials (NDC 55150-169-10) | Currently backordered | Additional quantities expected by early April | Demand increase for the drug |
| 0.5% 30 mL Single Dose Vials (NDC 55150-170-30) | Currently backordered | Additional quantities expected by early April | Demand increase for the drug |
| 0.75% 10 mL Single Dose Vials (NDC 55150-171-10) | Currently backordered | Additional quantities expected by late April | Demand increase for the drug |
| 0.75% 30 mL Single Dose Vials (NDC 55150-172-30) | Currently backordered | Additional quantities expected by early April | Demand increase for the drug |
| 0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50) | Currently backordered | Additional quantities expected by early April | Demand increase for the drug |
| 0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50) | Currently backordered | Additional quantities expected by early April | Demand increase for the drug |
Fresenius Kabi USA, LLC (Revised 03/04/2019)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57) | Backordered. Next release anticipated March 2019. | All Bupivacaine presentations are on intermittent back order and will be released as the product becomes available. Product will ship into the wholesalers. | Demand increase for the drug |
| Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-467-57) | Backordered. Next release anticipated March 2019. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-17) | Backordered. Next release March 2019. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37) | Backordered. Next release March 2019. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-464-31) | Backordered. Next release date not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-17) | Backordered. Next release March 2019. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, SDV (NDC 63323-466-37) | Backordered. Next release March 2019. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF, Sterile-Pak, SDV (NDC 63323-466-31) | Backordered. Next release date not available at this time. | Demand increase for the drug | |
| Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-17) | Available | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF, SDV (NDC 63323-472-37) | Available | Check wholesalers for inventory. | Demand increase for the drug |
Hospira, Inc. (Revised 02/28/2019)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01) | Next Delivery: March 2019; Estimated Recovery: November 2019 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02) | Next Delivery: March 2019; Estimated Recovery: June 2019 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01) | Next Delivery: February 2019; Estimated Recovery: June 2019 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01) | Next Delivery: March 2019; Estimated Recovery: September 2019 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02) | Next Delivery: March 2019; Estimated Recovery: June 2019 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01) | Next Delivery: February 2019; Estimated Recovery: September 2019 | Shortage per Manufacturer: Manufacturing Delay | Other |
| 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01) | Next Delivery: March 2019; Estimated Recovery: June 2019 | Shortage per Manufacturer: Manufacturing Delay | Other |
| 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02) | Next Delivery: June 2019; Estimated Recovery: September 2019 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL); Glass Ampul (NDC 00409-3613-01) | Available | Other | |
| Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10) | Next Delivery: March 2020; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30) | Next Delivery: June 2019; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50) | Next Delivery: March 2020; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10) | Next Delivery: March 2020; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29) | Next Delivery: March 2020; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50) | Next Delivery: June 2019; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10) | Next Delivery: March 2020; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29) | Next Delivery: March 2020; Estimated Recovery: June 2020 | Shortage per Manufacturer: Manufacturing Delay | Other |
| Marcaine Spinal 15 mg/2 mL (7.5 mg/mL); Glass Ampul (NDC 00409- 1761-02) | Available | Other |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English